Inventor
KATH JOHN CHARLES
US26 patents
⚠️ This page may combine multiple inventors who share the name “KATH JOHN CHARLES”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PFIZER
22 patentsUS8680111B2Mar 25, 2014
Macrocyclic derivatives for the treatment of diseases
PFIZER54 citations96
US6465449B1Oct 15, 2002
Heteroaromatic bicyclic derivatives useful as anticancer agents
PFIZER85 citations96
US6284764B1Sep 4, 2001
Substituted bicyclic derivatives useful as anticancer agents
PFIZER121 citations96
US6541481B2Apr 1, 2003
Substituted bicyclic derivatives useful as anticancer agents
PFIZER55 citations95
US7741336B2Jun 22, 2010
Pyrimidine derivatives for the treatment of abnormal cell growth
PFIZER18 citations92
US7351712B2Apr 1, 2008
Pyrimidine derivatives for the treatment of abnormal cell growth
PFIZER19 citations92
US7235562B2Jun 26, 2007
Pyrimidine derivatives for the treatment of abnormal cell growth
PFIZER34 citations92
US7208499B2Apr 24, 2007
Pyrimidine derivatives for the treatment of abnormal cell growth
PFIZER27 citations92
US7109337B2Sep 19, 2006
Pyrimidine derivatives for the treatment of abnormal cell growth
PFIZER33 citations92
US7109335B2Sep 19, 2006
Pyrimidine derivatives for the treatment of abnormal cell growth
PFIZER25 citations92
US6890924B2May 10, 2005
Substituted bicyclic derivatives for the treatment of abnormal cell growth
PFIZER34 citations92
US7122670B2Oct 17, 2006
Selective synthesis of CF3-substituted pyrimidines
PFIZER21 citations91
US7585869B2Sep 8, 2009
Substituted heterocylces for the treatment of abnormal cell growth
PFIZER22 citations90
US7145008B2Dec 5, 2006
Pyrimidine derivatives for the treatment of abnormal cell growth
PFIZER21 citations84
US9133215B2Sep 15, 2015
Macrocyclic derivatives for the treatment of diseases
PFIZER16 citations82
US6867201B2Mar 15, 2005
Heteroaromatic bicyclic derivatives useful as anticancer agents
PFIZER14 citations82
US7674796B2Mar 9, 2010
Pyrimidine derivatives for the treatment of abnormal cell growth
PFIZER4 citations74
US9260439B2Feb 16, 2016
Dihydropyrrolopyrimidine derivatives
PFIZER3 citations71
US6403587B1Jun 11, 2002
Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of MIP-1-α binding to its CCR 1 receptor
PFIZER12 citations70
US6673801B1Jan 6, 2004
Dihydroxyhexanoic acid derivatives
PFIZER2 citations53
US9290496B2Mar 22, 2016
Purine derivatives
PFIZER1 citations50
US9758538B2Sep 12, 2017
Pyrimidine derivatives
PFIZER0 citations40